PK ! xl/worksheets/sheet1.xml
0
1
23
45
67
89
1011
1213
PK ! \: : xl/workbook.xml
PK ! VV xl/sharedStrings.xml
Amneal Pharmaceuticals INCFull Year 2022 Financial GuidanceNet revenue$2.15 billion - $2.25 billionAdjusted EBITDA (1)$500 million - $520 millionAdjusted diluted EPS (2)$0.65 - $0.70Operating cash flow (3)$200 million - $225 millionCapital expenditures$65 million - $75 millionWeighted average diluted shares outstanding (4)Approximately 305 millionPK ! H$ $ docProps/app.xml
Microsoft Excel0falseWorksheets1amneal pharmaceuticals incfalsefalsefalse12.0000PK ! <0P P docProps/core.xml
2023-01-10T11:09:40Z2023-01-10T11:09:40ZPK ! a]I: [Content_Types].xml
PK ! '-(
xl/styles.xml
PK ! FTR R xl/theme/theme1.xml
PK ! IK K _rels/.rels
PK ! Du[ xl/_rels/workbook.xml.rels
PK ! xl/worksheets/sheet1.xmlPK ! \: : xl/workbook.xmlPK ! VV + xl/sharedStrings.xmlPK ! H$ $ T docProps/app.xmlPK ! <0P P docProps/core.xmlPK ! a]I: % [Content_Types].xmlPK ! '-(
xl/styles.xmlPK ! FTR R # xl/theme/theme1.xmlPK ! IK K 6 _rels/.relsPK ! Du[ 9 xl/_rels/workbook.xml.relsPK
<